Caisse De Depot Et Placement Du Quebec Neurocrine Biosciences Inc Transaction History

Caisse De Depot Et Placement Du Quebec

$50.2 Billion
Q3 2024

A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 736,910 shares of NBIX stock, worth $90.9 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

736,910

Previous 656,118 12.31%

Holding current value

$90.9 Million

Previous $90.3 Million 6.07%

% of portfolio

0.17%

Previous 0.22%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $9.26 Million - $12.4 Million	80,792 Added 12.31%	736,910 $84.8 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $66 Million - $72.2 Million	504,435 Added 332.56%	656,118 $90.3 Million
Q1 2024 May 14, 2024	BUY	$130.4 - $143.74 $10 Million - $11.1 Million	76,938 Added 102.93%	151,683 $20.9 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $1.5 Million - $1.88 Million	14,156 Added 23.36%	74,745 $9.85 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $10.2 Million - $12.7 Million	-108,080 Reduced 64.08%	60,589 $6.82 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $15.6 Million - $18.2 Million	-173,763 Reduced 50.74%	168,669 $15.9 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $28.1 Million - $36.7 Million	298,056 Added 671.66%	342,432 $34.7 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $2.29 Million - $2.73 Million	21,500 Added 93.98%	44,376 $5.3 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $1.9 Million - $2.22 Million	20,623 Added 915.36%	22,876 $2.43 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $1.71 Million - $2.25 Million	-22,516 Reduced 90.9%	2,253 $220,000
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $492,660 - $644,708	6,800 Added 37.84%	24,769 $2.32 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $103,545 - $138,086	-1,300 Reduced 6.75%	17,969 $1.53 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $344,720 - $396,120	4,000 Added 26.2%	19,269 $1.85 Million
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $1.37 Million - $1.56 Million	15,269 New	15,269 $1.49 Million

Others Institutions Holding NBIX

# of Institutions

624

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.

Account

Caisse De Depot Et Placement Du Quebec Neurocrine Biosciences Inc Transaction History